These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14694001)

  • 1. Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine.
    Harmel AP; Mathur R
    Diabetes Care; 2004 Jan; 27(1):272-3. PubMed ID: 14694001
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
    Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
    Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.
    Gallen IW; Carter C
    Diabetes Care; 2003 Dec; 26(12):3352-3. PubMed ID: 14633830
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
    Fahlén M; Eliasson B; Odén A
    Diabet Med; 2005 Apr; 22(4):382-6. PubMed ID: 15787660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 7. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.
    Schiaffini R; Ciampalini P; Spera S; Cappa M; Crinó A
    Diabetes Metab Res Rev; 2005; 21(4):347-52. PubMed ID: 15619291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glargine clinical trials.
    White JR
    Clin Ther; 2004 Jul; 26(7):1179-81; discussion 1182-3. PubMed ID: 15336483
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.
    Albright ES; Desmond R; Bell DS
    Diabetes Care; 2004 Feb; 27(2):632-3. PubMed ID: 14747268
    [No Abstract]   [Full Text] [Related]  

  • 10. [Flexible intensive insulin therapy: a change in mentalities].
    Penfornis A; Chabroux S; Grimaldi A
    Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes.
    Jackson A; Ternand C; Brunzell C; Kleinschmidt T; Dew D; Milla C; Moran A
    Pediatr Diabetes; 2003 Jun; 4(2):64-9. PubMed ID: 14655261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.
    Pickup JC; Renard E
    Diabetes Care; 2008 Feb; 31 Suppl 2():S140-5. PubMed ID: 18227475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting and insulin glargine in individuals with type 1 diabetes.
    Mucha GT; Merkel S; Thomas W; Bantle JP
    Diabetes Care; 2004 May; 27(5):1209-10. PubMed ID: 15111549
    [No Abstract]   [Full Text] [Related]  

  • 14. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
    Bragd J; von Döbeln A; Lins PE; Adamson U; Bergström J; Oskarsson P
    Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.
    Walczak IM
    Diabetes Technol Ther; 2002; 4(5):744-5. PubMed ID: 12458569
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome.
    Scaramuzza AE; Giani E; Riboni S; Spiri D; De Palma A; Mameli C; Zuccotti GV
    Diabetes Res Clin Pract; 2009 Aug; 85(2):e16-8. PubMed ID: 19595363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will the use of insulin analogs improve glycemic control during adolescence?
    Dunger DB
    Pediatr Diabetes; 2003 Jun; 4(2):61-3. PubMed ID: 14655260
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight].
    MMW Fortschr Med; 2005 Aug; 147(33-34):45. PubMed ID: 16138637
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
    Hirsch IB; Bode BW; Garg S; Lane WS; Sussman A; Hu P; Santiago OM; Kolaczynski JW;
    Diabetes Care; 2005 Mar; 28(3):533-8. PubMed ID: 15735183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.